171 related articles for article (PubMed ID: 16316299)
1. Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?
MacPhee IA; Fredericks S; Holt DW
Expert Opin Pharmacother; 2005 Dec; 6(15):2593-605. PubMed ID: 16316299
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.
Ng FL; Holt DW; MacPhee IA
Expert Opin Pharmacother; 2007 Sep; 8(13):2045-58. PubMed ID: 17714059
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.
Ekbal NJ; Holt DW; Macphee IA
Pharmacogenomics; 2008 May; 9(5):585-96. PubMed ID: 18466104
[TBL] [Abstract][Full Text] [Related]
4. The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administration.
Fredericks S; Holt DW; MacPhee IA
Am J Pharmacogenomics; 2003; 3(5):291-301. PubMed ID: 14575518
[TBL] [Abstract][Full Text] [Related]
5. Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.
Ware N; MacPhee IA
Curr Opin Mol Ther; 2010 Jun; 12(3):270-83. PubMed ID: 20521216
[TBL] [Abstract][Full Text] [Related]
6. Practicability of pharmacogenetics in transplantation medicine.
van Gelder T; van Schaik RH; Hesselink DA
Clin Pharmacol Ther; 2014 Mar; 95(3):262-4. PubMed ID: 23995265
[TBL] [Abstract][Full Text] [Related]
7. Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations.
Zhang X; Lin G; Tan L; Li J
Biomed Pharmacother; 2018 Jun; 102():107-114. PubMed ID: 29550633
[TBL] [Abstract][Full Text] [Related]
8. Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
Thervet E; Anglicheau D; Legendre C; Beaune P
Ther Drug Monit; 2008 Apr; 30(2):143-50. PubMed ID: 18367973
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?
Burckart GJ; Liu XI
Ther Drug Monit; 2006 Feb; 28(1):23-30. PubMed ID: 16418689
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.
van Gelder T; van Schaik RH; Hesselink DA
Nat Rev Nephrol; 2014 Dec; 10(12):725-31. PubMed ID: 25247332
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic biomarkers: cytochrome P450 3A5.
MacPhee IA
Clin Chim Acta; 2012 Sep; 413(17-18):1312-7. PubMed ID: 22037511
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of calcineurin inhibitors in renal transplantation.
Coto E; Tavira B
Transplantation; 2009 Aug; 88(3 Suppl):S62-7. PubMed ID: 19667964
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.
Szekeres T; Haushofer A
Pharmacogenomics; 2005 Mar; 6(2):163-8. PubMed ID: 15882134
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.
Cattaneo D; Baldelli S; Perico N
Am J Transplant; 2008 Jul; 8(7):1374-83. PubMed ID: 18510642
[TBL] [Abstract][Full Text] [Related]
15. Use of pharmacogenetics to optimize immunosuppressive therapy.
Macphee IA
Ther Drug Monit; 2010 Jun; 32(3):261-4. PubMed ID: 20431509
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
[TBL] [Abstract][Full Text] [Related]
17. Choosing the right dose of tacrolimus.
Lancia P; Jacqz-Aigrain E; Zhao W
Arch Dis Child; 2015 Apr; 100(4):406-13. PubMed ID: 25416736
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and tacrolimus administration in stem cell transplantation.
Patel JN; Hamadeh IS
Pharmacogenomics; 2020 Apr; 21(6):419-426. PubMed ID: 32308133
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors for individual administration of immunosuppressants in organ transplantation.
Yu SF; Wu LH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):337-44. PubMed ID: 16911928
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in solid organ transplantation: current status and future directions.
de Jonge H; Kuypers DR
Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
